A prospective, open-label, single-center phase 3 superiority study to assess the clinical nodal stage (cN-stage) accuracy of ferumoxtran-10 -enhanced Magnetic Resonance Imaging (MRI) and unenhanced MRI in reference to histopathologic pN-stage in newly diagnosed rectal cancer (RC) patients, scheduled for direct surgery or short course radiotherapy prior to surgery.
RecruitingCTIS2024-514831-34-00
Varsinais-Suomen hyvinvointialueMesorectal lymph node metastases, Rectal cancer
Start: 2024-09-19Target: 60Updated: 2024-10-24